These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15492789)

  • 21. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
    Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
    Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor 1 alpha expression increases during colorectal carcinogenesis and tumor progression.
    Simiantonaki N; Taxeidis M; Jayasinghe C; Kurzik-Dumke U; Kirkpatrick CJ
    BMC Cancer; 2008 Nov; 8():320. PubMed ID: 18983642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The expression of hypoxia-inducible factor 1alpha is a favorable independent prognostic factor in renal cell carcinoma.
    Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Vasko J; Ljungberg B
    Clin Cancer Res; 2005 Feb; 11(3):1129-35. PubMed ID: 15709180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neoangiogenesis and expression of hypoxia-inducible factor 1alpha, vascular endothelial growth factor, and glucose transporter-1 in endometrioid type endometrium adenocarcinomas.
    Ozbudak IH; Karaveli S; Simsek T; Erdogan G; Pestereli E
    Gynecol Oncol; 2008 Mar; 108(3):603-8. PubMed ID: 18191183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expressions of hypoxia inducible factor-1alpha and vascular endothelial growth factor in human renal cell carcinoma].
    Shao ZQ; Zheng SB; Xiao YJ; Tan WL; Chen T; Qi H; Jiang YD; Yu ZC; Zhang HJ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):1034-6. PubMed ID: 16109571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
    Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk.
    Knechtel G; Szkandera J; Stotz M; Hofmann G; Langsenlehner U; Krippl P; Samonigg H; Renner W; Langner C; Dehchamani D; Gerger A
    Mol Carcinog; 2010 Sep; 49(9):805-9. PubMed ID: 20572162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single nucleotide polymorphism in the extracellular domain of TRAIL receptor DR4 at nucleotide 626 in gastric cancer patients in Japan.
    Kuraoka K; Matsumura S; Sanada Y; Nakachi K; Imai K; Eguchi H; Matsusaki K; Oue N; Nakayama H; Yasui W
    Oncol Rep; 2005 Aug; 14(2):465-70. PubMed ID: 16012731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma.
    Hsiao PC; Chen MK; Su SC; Ueng KC; Chen YC; Hsieh YH; Liu YF; Tsai HT; Yang SF
    J Surg Oncol; 2010 Aug; 102(2):163-9. PubMed ID: 20648588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis.
    Krishnamachary B; Semenza GL
    Methods Enzymol; 2007; 435():347-54. PubMed ID: 17998062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of hypoxia-inducible factor-1alpha predicts an unfavorable outcome in urothelial carcinoma of the upper urinary tract.
    Ke HL; Wei YC; Yang SF; Li CC; Wu DC; Huang CH; Wu WJ
    Int J Urol; 2008 Mar; 15(3):200-5. PubMed ID: 18304212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
    Fu XS; Choi E; Bubley GJ; Balk SP
    Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma.
    Theodoropoulos VE; Lazaris AC; Kastriotis I; Spiliadi C; Theodoropoulos GE; Tsoukala V; Patsouris E; Sofras F
    BJU Int; 2005 Feb; 95(3):425-31. PubMed ID: 15679808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
    Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
    J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlations of expressions of Glut1 and HIF-1alpha to cellular proliferation of colorectal adenocarcinoma].
    Zhou YL; Deng CS
    Ai Zheng; 2005 Jun; 24(6):685-9. PubMed ID: 15946479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression and clinical significance of hypoxia-inducible factor-1alpha in gastric cancer].
    Han B; Xu RH; Shi YX; Li YH; Luo HY; Wang F; Hou JH; Cai MY; Jiang WQ
    Ai Zheng; 2006 Nov; 25(11):1439-42. PubMed ID: 17094917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A C/T polymorphism in the urokinase-type plasminogen activator gene in colorectal cancer.
    Przybylowska K; Smolarczyk K; Blasiak J; Kulig A; Romanowicz-Makowska H; Dziki A; Ulanska J; Pander B
    J Exp Clin Cancer Res; 2001 Dec; 20(4):569-72. PubMed ID: 11876553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.